Fen-Phen Risks Won’t Color U.S. FDA Diet Pill Review

Fen-Phen Risks Won’t Color U.S. FDA Diet Pill Review
U.S. regulators won’t re-examine safety data from fen-phen, the recalled diet drug tied to heart damage, as they review a new generation of weight-loss pills led by Vivus Inc.’s Qnexa that use some of the same ingredients.
Read more on BusinessWeek

Autism-related study discovers how drug interferes with neuronal cell function
A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function.
Read more on PhysOrg